血清HSP90A、STIP1和TAGLN-2水平在子宫腺肌病的临床诊断价值
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

上海市卫生局课题(2019LP078)


Clinical diagnostic value of serum HSP90A, STIP1 and TAGLN-2 levels in adenomyosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 观察血清热休克蛋白(HSP)90A、应激诱导磷蛋白1(STIP1)和肌动蛋白凝胶蛋白2(TAGLN-2)水平在子宫腺肌病的临床诊断价值。方法 选取2020年1月—2022年6月在复旦大学附属妇产科医院诊治的子宫腺肌病患者126例,为子宫腺肌病组。选取同期在该院行健康体检妇女65例,为对照组。影响子宫腺肌病形成进行单因素和多因素分析,观察血清HSP90A、STIP1和TAGLN-2水平与子宫腺肌病严重程度和痛经的关系,及其在诊断子宫腺肌病的诊断效能。结果 子宫腺肌病组孕次、产次、血清HSP90A、STIP1和TAGLN-2水平明显高于对照组(均P<0.01),而两组在年龄、BMI、人工流产史、分娩史、TG、TC、HDL-C和LDL-C水平差异无统计学意义(均P>0.05)。多因素分析发现孕次、产次、血清HSP90A、STIP1和TAGLN-2水平是影响子宫腺肌病的独立危险因素(均P<0.01)。血清HSP90A、STIP1和TAGLN-2水平随着子宫腺肌病的分级升高而升高(P<0.01),有痛经组的水平明显高于无痛经组(P<0.01)。血清HSP90A、STIP1和TAGLN-2水平在诊断子宫腺肌病发生的灵敏度分别为60.3%、77.0%和77.0%,特异度分为为92.3%、89.2%和76.9%,AUC分别为0.836、0.884和0.829,联合检测的灵敏度为92.9%,特异度为92.3%,AUC为0.966,明显高于单个指标的HSP90A(z=5.269,P<0.001)、STIP1(z=3.867,P<0.001)和TAGLN-2(z=5.286,P<0.001)。结论 HSP90A、STIP1和TAGLN-2参与了子宫腺肌病的发病过程,是子宫腺肌病严重程度的指标,联合检测有助于提高子宫腺肌病的诊断效能

    Abstract:

    Objective To investigate the clinical diagnostic value of serum heat shock protein (HSP) 90A, stress induced phosphoprotein 1 (STIP1) and transgelin 2 (TAGLN-2) levels in adenomyosis. Methods 126 patients with adenomyosis diagnosed and treated in the Obstetrics and Gynecology Hospital Affiliated to Fudan University from January 2020 to June 2022 were selected as adenomyosis group. 65 women who underwent physical examination in the hospital during the same period were selected as healthy control group. The influence on adenomyosis formation was analyzed by unifactor and multivariate analysis, the relationship among the serum HSP90A, STIP1 and TAGLN-2 levels, the severity and dysmenorrhea of adenomyosis were also observed, and the diagnostic efficacy was analyzed in the diagnosis of adenomyosis. Results The levels of pregnancy time, birth time, serum HSP90A, STIP1 and TAGLN-2 in adenomyosis group were significantly higher than those in healthy control group (P<0.01), but there were no significant differences in age, BMI, induced abortion history, delivery history, TG, TC, HDL-C and LDL-C between the two groups (P>0.05) Multivariate analysis showed that pregnancy time, birth time, serum HSP90A, STIP1 and TAGLN-2 levels were independent risk factors for adenomyosis (P<0.01) The serum levels of HSP90A, STIP1 and TAGLN-2 were increased with the grade of adenomyosis (P<0.01), and the levels in the group with dysmenorrhea were significantly higher than those in the group without dysmenorrhea (P<0.01) The sensitivity of serum HSP90A, STIP1 and TAGLN-2 levels in the diagnosis of adenomyosis was 60.3%, 77.0% and 77.0%, the specificity was 92.3%, 89.2% and 76.9%, and the AUC was 0.836, 0.884 and 0.829, respectively. The sensitivity and specificity of the combined detection were 92.9%, 92.3% and AUC was 0.966, which were significantly higher than that of the HSP90A (z=5.269, P<0.001), STIP1 (z=3.867, P<0.001) and TAGLN-2 (z=5.286, P<0.001).Conclusion HSP90A, STIP1 and TAGLN-2 are involved in the pathogenesis of adenomyosis and are the indicators of the severity of adenomyosis. Combined detection is helpful to improve the diagnostic efficiency of adenomyosis

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-05-20
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司